ConductScience.org, home

Paper42333641

Safety and Efficacy of Nerinetide at Year 1 in Participants Enrolled in ESCAPE-NEXT: A Multicenter, Double-Blind, Randomized Controlled Trial.

Adams C and 19 others. J Am Heart Assoc, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Safety and Efficacy of Nerinetide at Year 1 in Participants Enrolled in ESCAPE-NEXT: A Multicenter, Double-Blind, Randomized Controlled Trial. Papers, record 42333641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42333641

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Safety and Efficacy of Nerinetide at Year 1 in Participants Enrolled in ESCAPE-NEXT: A Multicenter, Double-Blind, Randomized Controlled Trial.
PubMed
Journal
J Am Heart Assoc
PubMed
Year
2026
PubMed
Publication types
Journal Article, Multicenter Study, Randomized Controlled Trial
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-20
PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Neuroprotective AgentsMajor topic
Ischemic StrokeMajor topic
StrokeMajor topic
Humans
Double-Blind Method
Female
Male
Time Factors
Aged
Treatment Outcome
Middle Aged
Peptide Fragments

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in42622147Correction to: Safety and Efficacy of Nerinetide at Year in Participants Enrolled in ESCAPE-NEXT: A Multicenter, Double-Blind, Randomized Controlled Trial.https://conductscience.org/library/papers/42622147

Source PubMed

Download CSV of comments and corrections

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134774198Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis.Lancet2022https://conductscience.org/library/papers/34774198PubMed
212399596Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions.Science2002https://conductscience.org/library/papers/12399596PubMed
341583582Nerinetide Reduces Early Infarct Growth Among Stroke Patients Undergoing EVT Without Intravenous Alteplase.Stroke Vasc Interv Neurol2024https://conductscience.org/library/papers/41583582PubMed
42749846Measurements of acute cerebral infarction: a clinical examination scale.Stroke1989https://conductscience.org/library/papers/2749846PubMed
523390923Endovascular therapy after intravenous t-PA versus t-PA alone for stroke.N Engl J Med2013https://conductscience.org/library/papers/23390923PubMed
622388811Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain.Nature2012https://conductscience.org/library/papers/22388811PubMed
732087818Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.Lancet2020https://conductscience.org/library/papers/32087818PubMed
818617669Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat.Stroke2008https://conductscience.org/library/papers/18617669PubMed
929364767Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging.N Engl J Med2018https://conductscience.org/library/papers/29364767PubMed
1033827973Plasmin-resistant PSD-95 inhibitors resolve effect-modifying drug-drug interactions between alteplase and nerinetide in acute stroke.Sci Transl Med2021https://conductscience.org/library/papers/33827973PubMed
1126022639Effect Size Estimates for the ESCAPE Trial: Proportional Odds Regression Versus Other Statistical Methods.Stroke2015https://conductscience.org/library/papers/26022639PubMed
1234841963Impact of minimal sufficient balance, minimization, and stratified permuted blocks on bias and power in the estimation of treatment effect in sequential clinical trials with a binary endpoint.Stat Methods Med Res2022https://conductscience.org/library/papers/34841963PubMed
1323035045A translational paradigm for the preclinical evaluation of the stroke neuroprotectant Tat-NR2B9c in gyrencephalic nonhuman primates.Sci Transl Med2012https://conductscience.org/library/papers/23035045PubMed
1410905241
Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score.
Lancet2000https://conductscience.org/library/papers/10905241PubMed
1539955120
Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind, placebo-controlled study.
Lancet2025https://conductscience.org/library/papers/39955120PubMed
1624076337High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial.Lancet Neurol2013https://conductscience.org/library/papers/24076337PubMed
1734484897Variability of the Modified Rankin Scale Score Between Day 90 and 1 Year After Ischemic Stroke.Neurol Clin Pract2021https://conductscience.org/library/papers/34484897PubMed
1826661213Efficacy of the PSD95 inhibitor Tat-NR2B9c in mice requires dose translation between species.J Cereb Blood Flow Metab2016https://conductscience.org/library/papers/26661213PubMed
1939955119
Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial.
Lancet2025https://conductscience.org/library/papers/39955119PubMed
2029129157Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct.N Engl J Med2018https://conductscience.org/library/papers/29129157PubMed

See all 27 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42333641

GET https://conductscience.org/api/papers/v1/42333641/references?page=2